Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Incannex Healthcare (IXHL) EBITDA Margin: 2020-2025

Historic EBITDA Margin for Incannex Healthcare (IXHL) over the last 6 years, with Jun 2025 value amounting to -54,302.33%.

  • Incannex Healthcare's EBITDA Margin fell 11710811.00% to -124,000.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 116,631.71%, marking a year-over-year change of. This contributed to the annual value of -54,302.33% for FY2025, which is 10016434.00% up from last year.
  • As of FY2025, Incannex Healthcare's EBITDA Margin stood at -54,302.33%, which was up 64.85% from -154,466.67% recorded in FY2024.
  • Over the past 5 years, Incannex Healthcare's EBITDA Margin peaked at -8.86% during FY2022, and registered a low of -154,466.67% during FY2024.
  • For the 3-year period, Incannex Healthcare's EBITDA Margin averaged around -70,827.04%, with its median value being -54,302.33% (2025).
  • Per our database at Business Quant, Incannex Healthcare's EBITDA Margin tumbled by 15,075,453bps in 2024 and then soared by 10,016,434bps in 2025.
  • Incannex Healthcare's EBITDA Margin (Yearly) stood at -651.38% in 2021, then soared by 64,252bps to -8.86% in 2022, then plummeted by 370,328bps to -3,712.14% in 2023, then slumped by 15,075,453bps to -154,466.67% in 2024, then skyrocketed by 10,016,434bps to -54,302.33% in 2025.